Pharmacy
Sun Pharma receives FDA approval for new alopecia areata treatment
Sun Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. Alopecia areata affects around 700,000 people in the United States, and 300,000 have severe alopecia areata.
Powering home health care: Navigating the complexities of Medicare Part B billing
Editor’s Note: Cardinal Health at-Home Solutions plays an instrumental role in providing patients and caregivers critical tools they need for care in the home.
Walmart expands autoimmune-focused care to 25 more pharmacies
BENTONVILLE, Ark. – Walmart announced the opening of 25 new autoimmune-focused Specialty Pharmacies of the Community across five states as part of a continued journey toward improving health outcomes for all. These 25 new locations come after debuting six last October.
PQA Diverse Quality Leaders Program receives ASAE Power of Associations Gold Award
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has received a 2024 Power of Associations Gold Award from the American Society of Association Executives (ASAE) for the PQA Diverse Quality Leaders Program.
Walmart Health spaces to become senior-focused primary care centers
Walmart Health Center locations in Florida, Georgia, Missouri and Texas are slated to become senior-focused primary care centers, Humana Inc.’s CenterWell health care services announced on Wednesday.
More proof for PBM reform: House Oversight Committee issues far-reaching report
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today praised a report on pharmacy benefit manager (PBM) middlemen issued by House Oversight and Accountability Committee Chairman James Comer (R-KY).
NCPA: Oversight PBM Hearing, report demand reforms and enforcement
ALEXANDRIA, Va. – The National Community Pharmacists Association released the following statement today from its CEO, B.
CVS Caremark defines future of pharmacy benefit management
CVS Caremark today announced a renewed pledge to American businesses, unions, and health plans — building on what the company is doing to deliver greater transparency, lower drug costs, and better clinical care for the most utilized health benefit.
Aurobindo gets FDA approval for dutasteride and tamsulosin hydrochloride capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for dutasteride and tamsulosin hydrochloride capsules 0.5 mg/0.4 mg.
Aurobindo receives FDA approval for baricitinib tablets
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application baricitinib tablets, 1mg and 2mg.
NACDS: House Oversight Hearing fuels PBM reform’s “must-pass” status
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today hailed the U.S.
Supply chain experts discuss the future of the U.S. pharmaceutical cold chain
Manufacturing, distributing and delivering cold chain pharmaceuticals poses unique challenges and opportunities for the healthcare supply chain.
PCMA issues statement on House Oversight Hearing
The Pharmaceutical Care Management Association (PCMA) released the following statement ahead of the U.S.
Walgreens gets BARDA Project NextGen Award for new study
Walgreens has received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will
